David-Alexandre C. Gros
Chief Executive Officer presso ELEDON PHARMACEUTICALS, INC.
Patrimonio netto: 18 540 $ in data 31/03/2024
Profilo
David-Alexandre C.
Gros was the founder of Imbria Pharmaceuticals, Inc. founded in 2018, where he held the title of Chairman & Chief Executive Officer.
He is also the founder of Eliem Therapeutics, Inc. Dr. Gros's current job is as Chief Executive Officer & Director at Eledon Pharmaceuticals, Inc. where he started in 2020.
Dr. Gros's former jobs include President, Chief Operating & Financial Officer at Neurocrine Biosciences, Inc. in 2017, Chief Strategy Officer & Executive Vice President at Sanofi from 2013 to 2015, Associate Principal at McKinsey & Co., Inc. from 2002 to 2006, Member-Supervisory Board at Saint Jean Groupe SA, Chief Financial Officer at Alnylam Pharmaceuticals, Inc. from 2016 to 2017, and Principal at Centerview Partners LLC from 2009 to 2011.
He also held the title of Chief Strategy Officer at Sanofi SA. Dr. Gros's education history includes an undergraduate degree from Dartmouth College in 1995, an MBA degree from Harvard Business School in 2002, and a doctorate degree from The Johns Hopkins University School of Medicine in 1999.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/05/2023 | 9 000 ( 0.04% ) | 18 540 $ | 31/03/2024 |
Posizioni attive di David-Alexandre C. Gros
| Società | Posizione | Inizio |
|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Chief Executive Officer | 09/09/2020 |
Precedenti posizioni note di David-Alexandre C. Gros
| Società | Posizione | Fine |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | President | 31/12/2017 |
| ALNYLAM PHARMACEUTICALS, INC. | Director of Finance/CFO | 06/01/2017 |
| SAINT JEAN GROUPE | Director/Board Member | 31/12/2015 |
| SANOFI | Corporate Officer/Principal | 01/06/2015 |
Centerview Partners LLC
 Centerview Partners LLC Investment Banks/BrokersFinance Centerview Partners LLC is a registered broker/dealer headquartered in New York City. The firm was founded by Robert Pruzan in 2006 and is a subsidiary of Centerview Partners Advisory Holdings LLC. Centerview Partners provides brokerage services to companies, institutions and governments. | Corporate Officer/Principal | 01/01/2011 |
Formazione di David-Alexandre C. Gros
| Dartmouth College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| SANOFI | Health Technology |
| SAINT JEAN GROUPE | Consumer Non-Durables |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| ELIEM THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Centerview Partners LLC
Centerview Partners LLC Investment Banks/BrokersFinance Centerview Partners LLC is a registered broker/dealer headquartered in New York City. The firm was founded by Robert Pruzan in 2006 and is a subsidiary of Centerview Partners Advisory Holdings LLC. Centerview Partners provides brokerage services to companies, institutions and governments. | Finance |
| Sanofi SA | Health Technology |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- David-Alexandre C. Gros
